Empagliflozin in Patients With Glomerulonephritis
NCT05283057
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Glomerulonephritis
Proteinuria
Interventions
DRUG:
Empagliflozin 25 MG
DRUG:
placebo
Sponsor
Kasr El Aini Hospital